The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) is a non-profit organization that connects the regenerative medicine community to the standards development process. With stakeholders from industry, academia, professional societies, and government entities, SCB occupies a unique niche within the regenerative medicine ecosystem and has no vested interests in a particular scientific, commercial, clinical, or policy approach. Our goal is to address stakeholder needs and support the advancement of standards that enhance the entire regenerative medicine community and accelerate innovation.